Beyond CBD, the C.sativa plant has over 100 rare bioactives, each offering its own, unique potential.
Category: All News
The Path to Commercializing Rare Bioactives
The demand for cleaner, more sustainable, and cost-effective bioactives across all industries has never been higher. Consumers want the option to “do better” – for themselves, others, and the planet. Companies are finding themselves in a new age of innovation where development of new, rare bioactives that deliver on promises is key to connecting with […]
Rare Access: Strain Engineering
Strain Engineering at Demetrix Our Rare Access interview this month features Rathin Bector, Senior Associate Scientist on the Strain Engineering team at Demetrix. Rathin focuses on designing quality strains at a high throughput. Click below to view the interview Hi Rathin, would you mind just letting people know your background and current role at […]
CBGA – The Mother Cannabinoid
CBGA is often referred to as the Mother Cannabinoid, however, it is not the parent for every known cannabinoid in the Cannabis sativa plant. Part of the confusion is that it is the parent to many of the common cannabinoids we see in the news such as, CBD, CBG, and THC. To better understand how […]
The Skin Microbiome – Part 2
In part 1 of the skin microbiome, we discussed the microorganisms living on your skin, why they’re beneficial, and how to keep them healthy. In part 2, we are exploring the relationship between the gut and skin microbiomes and the role of prebiotics and probiotics. What is the Gut Microbiome? Just like your skin, your […]
CEO Jeff Ubersax Discusses Cannabinoid sustainability
Demetrix CEO Jeff Ubersax was recently interviewed at the Global Cannabis Intelligence Summit. During the discussion he addressed the untapped potential of cannabinoids, how fermentation works, and the sustainability of fermentation. Click below to view the video Cannabinoids with Untapped Potential Currently, there is a lot of awareness around the benefits of THC and […]